Retrospective Cohort Study
Copyright ©The Author(s) 2023.
World J Gastroenterol. Mar 7, 2023; 29(9): 1492-1508
Published online Mar 7, 2023. doi: 10.3748/wjg.v29.i9.1492
Table 7 Multivariate analysis of the relationship between each dependent variable (binary variables 0/1: Screening colonoscopy performed beyond 7-mo; Serious adverse events, Yield of neoplasm at screening colonoscopy) and the predictive factors
Characteristics of the cohort of gastroenterologistsColo performed beyond a 7-mo risk analysis
Serious adverse events risk analysis
Neoplasms risk analysis
ORa, 95%CI
P1
ORa, 95%CI
P1
ORa, 95%CI
P1
Annual Nb of Colo (Ref: 1 Colo)
2-300.7 [0.6; 1.0]0.0022.5 [0.3; 18.2]0.370.9 [0.7; 1.1]0.41
> 300.7 [0.3; 0.9]0.0082.9 [0.9; 23.0]0.050.8 [0.6; 1.1]0.32
Place of S-colo performance (Ref: Clinic)
Private hospital1.2 [0.9; 1.6]0.180.7 [0.3; 1.8]0.471.1 [0.9; 1.3]0.41
Public hospital2.1 [1.3; 3.6]0.0011.6 [0.3; 8.7]0.601.1 [0.8; 1.4]0.20
Density of GE (Ref: Low)
Average0.9 [0.8; 1.0]0.051.2 [0.6; 2.2]0.591.0 [0.9; 1.1]0.76
High1.0 [1.0; 1.2]0.281.2 [0.6; 2.3]0.650.9 [0.8; 1.0]0.04
Annual Nb of S-colo locations (Ref: 1 location)
≥ 2 locations1.1 [0.8; 1.5]0.111.6 [0.5; 4;4]0.411.0 [0.8; 1.3]0.84
Residence of the patient (Ref: Colonoscopy’s supply municipality)
Other municipality in Colonoscopy’s supply department1.0 [0.9; 1.0]0.301.0 [0.5; 2.1]0.971.0 [0.9; 1.0]0.31
Other departments in IDF1.2 [1.1; 1.3]< 10-31.2 [0.3; 5.2]0.810.9 [0.8; 1.0]0.13
Age (yrs) of the patients (Ref: 50-54 yr)
55-590.9 [0.8; 1.0]0.031.6 [1.0; 2.6]0.041.3 [1.2; 1.4]< 10-3
60-640.8 [0.7; 0.9]0.0012.0 [1.2; 3.1]0.0061.6 [1.5; 1.6]< 10-3
65-690.7 [0.7; 0.8]< 10-31.9 [1.2; 3.0]0.011.7 [1.6; 1.8]< 10-3
≥ 700.7 [0.6; 0.8]0.0032.1 [1.3; 3.4]0.0021.7 [1.6; 1.8]< 10-3
Period (Ref.: gFOBT)
FIT1.2 [1.1; 1.2]< 10-30.8 [0.4; 1.5]0.111.6 [1.5; 1.7]< 10-3
STOP-FIT2.4 [2.1; 2.6]< 10-30.8 [0.5; 1.3]0.271.3 [1.1; 1.5]< 10-3
COVID2.0 [1.8; 2.2]< 10-30.5 [0.3; 0.9]0.021.1 [1.0; 1.3]0.08